Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $904.58M | $492.72M | +83.59% |
Operating Income | $-191.46M | $-640.38M | +70.10% |
Net Income | $-190.86M | $-692.79M | +72.45% |
EPS (Basic) | $-1.10 | $-7.04 | +84.37% |
EPS (Diluted) | $-1.10 | $-7.04 | +84.37% |
R&D Expense | $122.45M | $119.71M | +2.29% |
SG&A Expense | $523.23M | $644.06M | -18.76% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $2.28B | $971.73M | +134.78% |
Current Assets | $1.15B | $679.41M | +68.75% |
Total Liabilities | $1.77B | $918M | +93.20% |
Current Liabilities | $350.03M | $252.62M | +38.56% |
Stockholders' Equity | $507.82M | $53.73M | +845.18% |
Cash & Equivalents | $655.92M | $388.01M | +69.05% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-181.3M | $-149.79M | -21.03% |
Investing Cash Flow | $-387.64M | $-122.43M | -216.62% |
Financing Cash Flow | $887.73M | $494.51M | +79.52% |
Dividends Paid | $0 | $5.63M | -100.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -21.2% | -130.0% | +108.80% |
Net Margin | -21.1% | — | — |
ROE | -37.6% | — | — |
ROA | -8.4% | — | — |
Current Ratio | $3.275 | — | — |
Debt to Equity | $3.493 | — | — |
Other companies in Life Sciences Tools & Services